Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 40Colorectal Neoplasms 9Adenocarcinoma 8Esophageal Neoplasms 7Carcinoma, Hepatocellular 7Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma Of Esophagus 5Neoplasm Metastasis 4Rectal Neoplasms 3Liver Neoplasms 3Carcinoma, Renal Cell 3Biliary Tract Neoplasms 3Urinary Bladder Neoplasms 2Pancreatic Neoplasms 2Metastatic Gastric Adenocarcinoma 2Melanoma 2Cholangiocarcinoma 2Urethral Neoplasms 1Ureteral Neoplasms 1Sarcoma, Alveolar Soft Part 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neoplasms by Site 1Lymphoma, Mantle-Cell 1Locally Advanced Unresectable Gastric Adenocarcinoma 1Liver Diseases 1Head and Neck Neoplasms 1HER2-positive Gastric Cancer 1

Interventions

apatinib 9Paclitaxel 9Capecitabine 7Oxaliplatin 6camrelizumab 5Cisplatin 5S 1 (combination) 4Fluorouracil 3Docetaxel 3130-nm albumin-bound paclitaxel 3titanium silicide 2Leucovorin 2Drug Therapy 2vorolanib 1trifluridine tipiracil drug combination 1tipiracil 1spartalizumab 1rucaparib 1relatlimab 1raltitrexed 1pazopanib 1olaparib 1lobaplatin 1linrodostat 1ezogabine 1endostar protein 1durvalumab 1dacomitinib 1capivasertib 1Trifluridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Gastric Cancer × Ramucirumab × Gastrointestinal × Clear all
NCT06169410 2024-01-23

Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer

Xijing Hospital

Phase 4 Unknown
140 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡